JY231
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for JY231, covering 2024-11-07 to 2025-07-15. Get the full timeline:
Most recent: Clinical Trial Update: JY231(JY231) Injection for the Treatment of R/R B-cell Malignancies [NA]